Teppler H, McCarroll K, Gesser RM, Woods GL (2002) Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam. Surg Infect (Larchmt) 3:337-349Teppler Hedy,McCarroll Kathleen,Gesser Richard M,Woods Gail L.Surgical infections with enterococcus: ...
Structure of Enterococcus faeciuml,d-transpeptidase acylated by ertapenem provides insight into the inactivation mechanism. The maintenance of bacterial cell shape and integrity is largely attributed to peptidoglycan, a biopolymer highly cross-linked through d,d-transpeptidation... L Lecoq,V Dubée,S ...
Ceftaroline (CPT), ertapenem (ERT), ampicillin (AMP), cefepime (FEP) and ceftriaxone (CRO) demonstrated synergy with DAP in time-kill studies. However, DAP synergy was observed with cefazolin (CFZ) and cefotaxime (CTX) only in one strain (R7808). In DAP binding studies, ceftaroline ...
faecalis (381) Ciprofloxacin Clarithromycin Clindamycin Dalbavancin 45.4 19.2 35.4 no BPb no BPb no BPb Daptomycin Ertapenem 100 no BPb Levofloxacin 65.6 1.1 33.3 Linezolid Meropenem Pip-Tazo Tigecycline 99.5 no BPb no BPb 97.9d 0.5 Vancomycin 100 E.faecium (150) Ciprofloxacin Clarithromycin ...
The Role of Ertapenem for the Treatment of Complicated Intra-abdominal Infections With a Positive Culture for Enterococcus faecalis.doi:10.1093/ofid/ofy339Valeria FabreKoorosh NematiEdina AvdicSara E CosgroveJoe AmoahPranita D TammaOxford University Press...
Ceftaroline (CPT), ertapenem (ERT), ampicillin (AMP), cefepime (FEP) and ceftriaxone (CRO) demonstrated synergy with DAP in time-kill studies. However, DAP synergy was observed with cefazolin (CFZ) and cefotaxime (CTX) only in one strain (R7808). In DAP binding studies, ceftaroline ...
and recently a linezolid-resistance mechanism has been described inE. faeciumand resistant strains have been isolated [6,11,12,14]. Other antibiotics, such as fosfomycin or ertapenem, and new combinations with the above last resort antibiotics (for example daptomycin with ceftaroline ertapenem, linezo...
Today, Enterococcus faecalis is one of the main causes of infective endocarditis in the world, generally affecting an elderly and fragile population, with a high mortality rate. Enterococci are partially resistant to many commonly used antimicrobial agen